Godavari Biorefineries Limited · NSE:GODAVARIB
Godavari Biorefineries — Q3 FY26 Earnings Presentation
30 slides from Godavari Biorefineries's earnings presentation, Feb 18, 2026
Slide 1: Investor Presentation Intimation to Stock Exchanges
Dated: February 18, 2026 The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Tower, Bandra Kurla Complex, Bandra (E), Dalal Street Mumbai – 400 051 Mumbai-400001 Script Symbol: GODAVARIB S
Slide 2: Investor Presentation Q3 & 9M FY26
www.godavaribiorefineries.com CREATING A BEAUTIFUL WORLD With Innovation at the Core, Unified in Growth, Sustainability & Inclusivity. Godavari Biorefineries Limited Investor Presentation Q3 & 9M FY26
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Godavari Biorefineries Limited (the “Company’), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for an
Slide 4: Godavari Biorefineries Limited's Guiding Principles
Godavari Biorefineries Limited's Guiding Principles Samir Somaiya Chairman & Managing Director 3
Slide 5: Company Snapshot
Company Snapshot Business Performance R&D and Innovation Consumer Brand Q3 FY26 Highlights Bio-based Specialty Chemicals Jivana Performance Consolidated Collaboration with Synthomer enables us to produce • Revenue growth of 2.5% YoY bio-butanol-based Butyl acrylate, driving our shared • Revenue reac
Slide 6: GBL Key Revenue, Growth Drivers & Business Updates
GBL Key Revenue, Growth Drivers & Business Updates In tune with Green Transitions in India & The World GBL’s Continued Focus on Bio-based Chemicals GBL’s Progress in Ethanol • Increase in Capacity and Capacity Utilisation • Increase in Revenue from Bio-Based Specialty Chemicals Business • Diversific
Slide 7: Q3 & 9M FY26 Business Performance
Q3 & 9M FY26 Business Performance
Slide 8: Q3 FY26 Performance Highlights (Y-o-Y Basis)
Q3 FY26 Performance Highlights (Y-o-Y Basis) (Consolidated) Total Income EBITDA* PBT# Rs. 461.9 Crs Rs. 45.1 Crs Rs. 21.4 Crs 2.5% YoY Margin 9.8% Margin 4.6% EBITDA* (Rs. Crs) PBT # (Rs. Crs) Finance Cost (Rs. Crs) +5.5 +12.9 -8.6 45.1 21.4 18.9 39.7 10.2 8.5 Q3 FY25 Q3 FY26 Q3 FY25 Q3 FY26 Q3 FY25
Slide 9: 9M FY26 Performance Highlights (Y-o-Y Basis)
9M FY26 Performance Highlights (Y-o-Y Basis) (Consolidated) Total Income EBITDA* PBT# Rs. 1,430.2 Crs Rs. 47.2 Crs Rs. (31.2) Crs 10.2% YoY Margin 3.3% Margin (2.2%) EBITDA* (Rs. Crs) PBT # (Rs. Crs) Finance Cost (Rs. Crs) (31.2) -20.9 +48.6 47.2 (97.3) 58.7 +66.1 37.8 (1.4) 9M FY25 9M FY26 9M FY25
Slide 10: Revenue-Mix (Y-o-Y Basis)
Revenue-Mix (Y-o-Y Basis) (Consolidated) Q3 FY25 Revenue-Mix * Q3 FY26 Revenue-Mix * 1% 1% 30% 29% 39% 39% 31% 31% Sugar & Cogen Bio-based chemicals Ethanol Unallocated *Some of the business segments are of seasonal nature and accordingly impact the results in the respective quarters Note: Percentag
Slide 11: Revenue-Mix (Y-o-Y Basis)
Revenue-Mix (Y-o-Y Basis) (Consolidated) 9M FY25 Revenue-Mix * 9M FY26 Revenue-Mix * 1% 2% 26% 31% 37% 41% z 31% 30% Sugar & Cogen Bio-based chemicals Ethanol Unallocated *Some of the business segments are of seasonal nature and accordingly impact the results in the respective quarters Note: Percent
Slide 12: Q3 FY26 Segmental Highlights-Bio-based Chemicals
Q3 FY26 Segmental Highlights-Bio-based Chemicals (Consolidated) Revenue (Rs. Crs) Q3 FY25 Q3 FY26 YoY Growth 137.1 142.3 3.8% Accelerating Growth Through Specialty Chemicals Revenue Break-up EBITDA (Rs. Crs) EBITDA Margin +4.8 +317 bps 46% 38% 10.9 7.7% 54% 62% 6.2 4.5% Q3 FY25 Q3 FY26 Q3 FY25 Q3 FY
Slide 13: 9M FY26 Segmental Highlights-Bio-based Chemicals
9M FY26 Segmental Highlights-Bio-based Chemicals (Consolidated) Revenue (Rs. Crs) 9M FY25 9M FY26 YoY Growth 403.1 430.6 6.8% Accelerating Growth Through Specialty Chemicals Revenue Break-up EBITDA (Rs. Crs) EBITDA Margin +285 bps +13.9 46% 38% 38.2 8.9% 62% 24.3 6.0% 54% 9M FY25 9M FY26 9M FY25 9M
Slide 14: Q3 FY26 Segmental Highlights- Ethanol
Q3 FY26 Segmental Highlights- Ethanol (Consolidated) Revenue (Rs. Crs) Q3 FY25 Q3 FY26 YoY Growth 173.3 132.3 (23.6%) Revenue (Rs. Crs) EBITDA (Rs. Crs) -41.0 -5.4 173.3 9.6 132.3 4.2 Q3 FY25 Q3 FY26 Q3 FY25 Q3 FY26 13
Slide 15: 9M FY26 Segmental Highlights- Ethanol
9M FY26 Segmental Highlights- Ethanol (Consolidated) Revenue (Rs. Crs) 9M FY25 9M FY26 YoY Growth 339.0 438.9 29.5% Revenue (Rs. Crs) EBITDA (Rs. Crs) 438.9 +3.8 +100 339.0 22.0 18.1 9M FY25 9M FY26 9M FY25 9M FY26 Availability of B-heavy molasses ethanol after a prolonged pause led to higher sales
Slide 16: Q3 FY26 Segmental Highlights- Sugar & Co-Generation
Q3 FY26 Segmental Highlights- Sugar & Co-Generation (Consolidated) Revenue (Rs. Crs) Q3 FY25 Q3 FY26 YoY Growth 133.0 180.9 36.1% Revenue Break-up (In %) EBITDA (Rs. Crs) 18% 18% +7.0 1% 6% 1% 4% 32.1 25.1 76% 77% Q3 FY25 Q3 FY26 Q3 FY25 Q3 FY26 Non Branded Sugar Branded Sugar Co-generation Others 1
Slide 17: 9M FY26 Segmental Highlights- Sugar & Co-Generation
9M FY26 Segmental Highlights- Sugar & Co-Generation (Consolidated) Revenue (Rs. Crs) 9M FY25 9M FY26 YoY Growth 533.0 532.9 - Revenue Break-up (In %) EBITDA (Rs. Crs) 14% 18% -8.5 2% 6% 5% 5% -40.5 +32.0 79% 73% 9M FY25 9M FY26 9M FY25 9MFY26 Non Branded Sugar Branded Sugar Co-generation Others 16
Slide 18: Consolidated Profit & Loss Statement – Q3 & 9M FY26
Consolidated Profit & Loss Statement – Q3 & 9M FY26 Particulars (in INR Cr) Q3 FY26 Q3 FY25 Y-o-Y Q2 FY26 Q-o-Q 9M FY26 9M FY25 Y-o-Y Revenue from Operations 459.9 447.3 2.8% 430.8 6.8% 1,423.8 1,290.7 10.3% Other Income 2.1 3.6 3.5 6.3 7.4 Total Income 461.9 450.8 2.5% 434.3 6.4% 1,430.2 1,298.2 10
Slide 19: R&D and Innovations
Godavari Biorefineries Ltd R&D and Innovations
Slide 20: Strategic Collaboration for Lower Carbon Footprint
Strategic Collaboration for Lower Carbon Footprint 19
Slide 21: Revolutionary Technology to Combat Climate Change
Revolutionary Technology to Combat Climate Change Converts Industrial CO2 Emissions directly into Dimethyl Ether (DME) – Pilot on Track • Sustainable Energy for the Future: DME’s versatility as a clean fuel and chemical carrier supports the global transition to renewables. • A Climate Game-Changer
Slide 22: Road to Drug Discovery
Road to Drug Discovery Developing Innovative Therapies For Difficult-To-Treat Cancers New Development: Sathgen Therapeutics LLC incorporated in the United States as a wholly owned step-down subsidiary to market our IP and pursue licensing partnerships. • Oral First-In-Class novel chemical entity • R
Slide 23: Road to Drug Discovery
Road to Drug Discovery Drug Discovery for Triple-Negative Breast Cancer (Promising preclinical efficacy in Tripple Negative Breast Cancer) Next Step In Process Preliminary Efficacy Mechanism of Trials: Out-licensing of Pre-Clinical Safety Action Preparation of Molecule Trials Trials Application Ther
Slide 24: Consumer Brand
Godavari Biorefineries Ltd Consumer Brand
Slide 25: Jivana - The Pure, Chemical Free, Sustainable Food Brand
Jivana - The Pure, Chemical Free, Sustainable Food Brand Clean & Healthy products for the aware consumer. Growing Sales 01 • Revenue reached Rs. 100 Crs in 9M FY26, up from Rs. 79 Crs in 9M FY25. • Revenue growth from Rs. 28 Crs in FY22 to Rs. 108 Crs in FY25 with a CAGR of 56%. Deeper Brand Penetra
Slide 26: Company Overview
ry ha Godavari Biorefineres Ltd Company Overview
Slide 27: Integrated Bio-refinery Across the Value Chain
Integrated Bio-refinery Across the Value Chain Sugar, Ethanol, Bio-Chemicals, Power & Others Planned Products GRAIN BASED ETHANOL SPECIALTY CHEMICALS Current Products 26
Slide 28: Board of Directors
Board of Directors The Visionary Shri Somaiya has been Conferred with the ‘Knight of the Order of the Star of Italy’, conferred with ‘Lala Shriram National Award for Leadership in the Chemical Industry’ by the Indian Institute of Chemical Engineers (2022), and is a proud recipient various awards inc
Slide 29: Board of Directors
Board of Directors Hemant Luthra Prof. Lakshmi Kantam Mannepalli Kumar L Desai (Independent Director) (Independent Director) (Independent Director) Mr Luthra holds a Bachelors’ degree of technology Prof Lakshmi holds a Doctor of Philosophy degree ( Mr Desai holds Bachelors’ degree of law from in Mec
Slide 30: Thank You
Thank You Godavari Biorefineries Ltd CIN: L67120MH1956PLC009707 Name – Mr. Ashish Sinha Title – AGM- IR & Finance investorrelations@somaiya.com Email – investorrelations@somaiya.com Ms. Prachi Ambre Mr. Irfan Raeen +91 83559 85370 Prachi.ambre@in.mpms.mufg.com +91 97737 78669 irfan.raeen@in.mpms.muf
Godavari Biorefineries — Q3 FY26 Earnings Presentation on 6ix